Press release
Vulva Cancer Market Dynamics, Segments and Supply Demand 2017 - 2025
Women who are infected with human papillomavirus (HPV) are at a higher risk of developing vulva cancer. Although the most common cause is viral infection, but factors such as smoking, diabetes, hypertension, immune system deficiency, lichen sclerosus, and presence of precancerous conditions such as vulvar intraepithelial neoplasia, increase the risk of vulva cancer. Vulva cancer is the fourth most common gynecologic cancer comprising of 4.7% of malignant neoplasms in the genital tract.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26603
Based on predisposing factor, the vulva cancer market is segmented as human papillomavirus-associated vulva cancer and human papillomavirus unassociated vulva cancer. The human papillomavirus-associated vulva cancer segment is expected to grow as 50%-75% of vulva cancer cases are due to human papillomavirus infection. Based on type, the market is classified as squamous cell carcinoma, adenocarcinoma, basal cell carcinoma, vulvar melanoma, and vulvar sarcoma.
The squamous cell carcinoma segment is projected to grow as 95% of the vulvar cancer are squamous cell carcinoma, followed by melanoma and sarcoma. Based on treatment, the market is segmented as surgery, radiation, and chemotherapy. The surgery segment includes laser surgery, vulvectomy, pelvic exenteration, and excision. The chemotherapy segment involves the use of drugs that kill and control the growth of cancerous cell. Chemotherapy may also include monotherapy or a combination of two or more drugs depending upon the type of cancer and rate of progression.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=26603
The chemotherapy segment is expected to grow due to the development of new molecules such as nivolumab by Bristol-Myers Squibb Company for the treatment of vulva cancer. Increase in incidence rate, development of new therapies such as biologics, burden of human papillomavirus infection in women, increase in incidence of sexually transmitted diseases, and less surveillance rate are the factors boosting the growth of the vulva cancer market. However, high cost of therapy and side effects associated with it are factors hampering the growth of the vulva cancer market.
Geographically, the vulva cancer market is dominated by North America, followed by Europe, due to increase in incidence rate, rise in geriatric population, and growth in research and development expenditure. Asia Pacific is an emerging market due to the developing health care infrastructure, increase in incidence rate, and rising government expenditure in the health care industry. Factors such as rising awareness about vulva cancer and improving economy are driving the vulva cancer market in Middle East & Africa. However, high cost of therapy and lack of proper treatment are restraining the growth of the Middle East & Africa market.
Obtain Report Details @ https://www.transparencymarketresearch.com/vulva-cancer-market.html
Key players operating in the vulva cancer market include ISA Pharmaceuticals B.V., Ono Pharmaceutical Co., Ltd., ORYX GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Celgene Corporation, Bristol-Myers Squibb Company, Johnson & Johnson, PDS Biotechnology Corporation, Novartis AG, Merck & Co., Pfizer Inc., and Amgen Inc.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vulva Cancer Market Dynamics, Segments and Supply Demand 2017 - 2025 here
News-ID: 966933 • Views: …
More Releases from Transparency Market Research
Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion …
The global medium voltage fuse market is steadily transitioning from a traditional grid-protection niche to a strategic enabler of modern power systems. Rising investments in renewable energy integration, large-scale electrification programs, and infrastructure upgrades are reshaping demand patterns worldwide. Medium voltage fuses-typically rated between 1 kV and 35 kV-are no longer viewed as passive safety components; instead, they are increasingly recognized as critical assets for grid stability, asset protection, and…
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 …
The global lamination films market was valued at US$ 8,123.4 million in 2023 and is forecast to reach US$ 8,514.1 million in 2024. Over the forecast period from 2024 to 2032, the market is projected to expand at a compound annual growth rate (CAGR) of 4.6%, ultimately exceeding US$ 12,213.1 million by 2032. This steady growth trajectory reflects the indispensable role of lamination films in modern packaging ecosystems across food,…
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth …
The global curcumin market is entering a structurally strong growth phase, underpinned by rising consumer preference for natural, plant-based ingredients and increasing clinical validation of curcumin's antioxidant and anti-inflammatory properties. As consumers shift away from synthetic additives and chemical-based therapeutics, curcumin is emerging as a high-value bioactive ingredient across , functional foods, cosmetics, and pharmaceuticals. Premiumization trends in organic products, combined with regulatory validation from food safety authorities, are expected…
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - …
The global Hemoglobin A1c (HbA1c) Testing Devices Market was valued at US$ 1.4 Bn in 2023 and is projected to expand at a CAGR of 7.7% from 2024 to 2034, reaching more than US$ 3.3 Bn by the end of 2034. The market growth is primarily attributed to the increasing global burden of diabetes, growing awareness about disease management, and technological advancements in diagnostic devices.
Get a concise overview of key…
More Releases for Vulva
Global Vulvar Cancer Treatment Market to Register Exponential Growth During COVI …
Vulvar Cancer is a rare type of cancer in which cancer cells form in the tissues of a vulva. It mostly affects the organs of external genital which protect a reproductive system of a woman. The risk of vulvar cancer mostly affected by vulvar cervical dysplasia and human papillomavirus infection. When cancer originates in the vulva, called primary vulvar cancer; if it spreads another part of the body it is…
Colposcopes Market is anticipated to grow with the highest CAGR during forecasts …
The Latest Study Report On Colposcopes Market
Colposcopes is a surgical instrument used for close examination of cervix, vagina and vulva for diagnostics purposes. Technologically advanced colposcopes contain electronic green filter and high-resolution camera which helps doctor or gynaecologist for examining infected area on screen. The process of examining cervix vagina and vulva to detect infection with colposcopes is known as colposcopy.
Increasing prevalence of diseases and problems related to cervix, vagina,…
Vulvar Cancer Treatment Market By Top Key Players- AstraZeneca Pharmaceuticals L …
"Vulvar Cancer Treatment Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025" is the latest addition to MarketResearchReports.Biz industry research reports collection.
Vulvar Cancer is a rare type of cancer in which cancer cells form in the tissues of a vulva. It mostly affects the organs of external genital which protect a reproductive system of a woman. The risk of vulvar cancer mostly affected by vulvar…
Colposcopy Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Colposcopy market.
Colposcopy is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through the examination. It is done using a colposcopy, which provides an enlarged view of…
Ongoing Forecast Study on Vulvar Cancer Treatment Market to Reveal Key Insights …
Vulvar Cancer is a rare type of cancer in which cancer cells form in the tissues of a vulva. It mostly affects the organs of external genital which protect a reproductive system of a woman. The risk of vulvar cancer mostly affected by vulvar cervical dysplasia and human papillomavirus infection. When cancer originates in the vulva, called primary vulvar cancer; if it spreads another part of the body it is…
Vulva Cancer Market – Overview of key forces propelling and restraining market …
Vulva cancer is rare type of cancer which forms in a woman’s external genitalia called the vulva. The vulva is an area of the skin that surrounds the vagina and urethra, including mons pubis, perineum, labia, bartholin glands, and clitoris. The labia majora is the most common site to develop vulva cancer. The cancer can occur at any age but primarily affects older women over the age of 65 years.…
